Transforming growth factor-β (TGF-β) signaling has been widely postulated to be excessively activated as the final common pathway causing fibroproliferative disease and fibrosis including the pulmonary fibrosis [3, 4], via Smad3 signaling [5]. The gene discussed is TGFB1; the disease is pulmonary fibrosis.